Literature DB >> 2493482

Induction of resistance to Schistosoma mansoni infection in mice by purified parasite paramyosin.

T P Flanigan1, C H King, R R Lett, J Nanduri, A A Mahmoud.   

Abstract

Freeze-thaw (FT)-disrupted schistosomula or their membrane extract induced significant resistance in mice to Schistosoma mansoni infection (34 and 25%, respectively) without the use of adjuvant. Antigens identified in schistosome extracts by sera from immunized animals were then evaluated for protective potential. Immunization with schistosomal antigens of 97 and 68-70 kD resulted in significant protection that was equivalent to that obtained by FT schistosomula. Since the 97-kD antigen was suggested to be parasite paramyosin, we used a biochemical technique to purify this muscle protein. Purified schistosome paramyosin ran as a single band on 10% SDS-PAGE and was recognized both by sera from mice immunized with FT schistosomula and a polyclonal antiserum raised against the 97-kD parasite protein. Preincubation of schistosome paramyosin with sera from mice immunized with FT schistosomula resulted in the removal of reactivity with the 97-kD protein in crude worm extracts. Paramyosin was identified by Western blotting to be in the tegument of schistosomula. The purified schistosome paramyosin resulted in significant protection in three separate experiments (24, 46, and 53%) without the use of adjuvant. Addition of BCG to paramyosin resulted in enhanced protection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493482      PMCID: PMC303778          DOI: 10.1172/JCI113942

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Identification of paramyosin as schistosome antigen recognized by intradermally vaccinated mice.

Authors:  D E Lanar; E J Pearce; S L James; A Sher
Journal:  Science       Date:  1986-10-31       Impact factor: 47.728

2.  Molecular cloning of a protective antigen of schistosomes.

Authors:  J M Balloul; P Sondermeyer; D Dreyer; M Capron; J M Grzych; R J Pierce; D Carvallo; J P Lecocq; A Capron
Journal:  Nature       Date:  1987 Mar 12-18       Impact factor: 49.962

3.  Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. IV. Fractionation and antigenic properties of a soluble adult worm immunoprophylactic activity.

Authors:  A Sher; E Pearce; S Hieny; S James
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

4.  Paramyosin and actin in schistosomal teguments.

Authors:  Y Matsumoto; G Perry; R J Levine; R Blanton; A A Mahmoud; M Aikawa
Journal:  Nature       Date:  1988-05-05       Impact factor: 49.962

5.  Vaccination against Schistosoma mansoni with purified surface antigens.

Authors:  M A Smith; J A Clegg
Journal:  Science       Date:  1985-02-01       Impact factor: 47.728

6.  Matching molecules in the catch mechanism.

Authors:  C Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

7.  Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen.

Authors:  E J Pearce; S L James; S Hieny; D E Lanar; A Sher
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  Induction of protective immunity against Schistosoma mansoni by a non living vaccine. I. Partial characterization of antigens recognized by antibodies from mice immunized with soluble schistosome extracts.

Authors:  S L James; E J Pearce; A Sher
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

9.  Isolation and characterization of a protective antigen for adjuvant-free immunization against Schistosoma mansoni.

Authors:  C H King; R R Lett; J Nanduri; S el Ibiary; P A Peters; G R Olds; A A Mahmoud
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

10.  Immunochemical characterization and purification of Sm-97, a Schistosoma mansoni antigen monospecifically recognized by antibodies from mice protectively immunized with a nonliving vaccine.

Authors:  E J Pearce; S L James; J Dalton; A Barrall; C Ramos; M Strand; A Sher
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

View more
  15 in total

1.  Immunogenicity of two Echinococcus granulosus antigens EgA31 and EgTrp in mice.

Authors:  M Fraize; M E Sarciron; S Azzouz; N Issaadi; G Bosquet; A F Petavy
Journal:  Parasitol Res       Date:  2005-04-12       Impact factor: 2.289

2.  Identification of paramyosin T cell epitopes associated with human resistance to Schistosoma mansoni reinfection.

Authors:  C T Fonseca; E Cunha-Neto; A C Goldberg; J Kalil; A R de Jesus; E M Carvalho; R Correa-Oliveira; J Hammer; J Sidney; A Sette; S C Oliveira
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

3.  Vaccination with recombinant paramyosin in Montanide ISA206 protects against Schistosoma japonicum infection in water buffalo.

Authors:  Hannah Wei Wu; Zhi-Qiang Fu; Ke Lu; Sunthorn Pond-Tor; Rui Meng; Yang Hong; Kai Chu; Hao Li; Mario Jiz; Jin-Ming Liu; Ming Hou; Sangshin Park; Jiao-Jiao Lin; Jonathan D Kurtis
Journal:  Vaccine       Date:  2017-05-11       Impact factor: 3.641

4.  Differential antigen-stimulated proliferation of human mononuclear cells by recombinant Schistosoma japonicum antigens in a Chinese population.

Authors:  G J Waine; W Yang; A G Ross; Y S Li; A C Sleigh; B H Kalinna; J C Scott; D Mazzer; Y Li; D P McManus
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

5.  Paramyosin of Echinococcus granulosus: cDNA sequence and characterization of a tegumental antigen.

Authors:  F Mühlschlegel; L Sygulla; P Frosch; P Massetti; M Frosch
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

6.  Molecular cloning and characterization of a paramyosin from Clonorchis sinensis.

Authors:  Tae-Joon Park; Jung-Mi Kang; Byoung-Kuk Na; Woon-Mok Sohn
Journal:  Korean J Parasitol       Date:  2009-12-01       Impact factor: 1.341

7.  Inhibition of the complement membrane attack complex by Schistosoma mansoni paramyosin.

Authors:  Jiusheng Deng; Daniel Gold; Philip T LoVerde; Zvi Fishelson
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

8.  Cloning and characterization of Taenia saginata paramyosin cDNA.

Authors:  Elizabeth Ferrer; Eva Moyano; Laura Benitez; Luis Miguel González; Denise Bryce; Mildred Foster-Cuevas; Iris Dávila; Maria Milagros Cortéz; Leslie J S Harrison; R Michael E Parkhouse; Teresa Gárate
Journal:  Parasitol Res       Date:  2003-07-25       Impact factor: 2.289

9.  Immune response induced by candidate Sarcoptes scabiei var. cuniculi DNA vaccine encoding paramyosin in mice.

Authors:  Xiaobin Gu; Yue Xie; Shuxian Wang; Xuerong Peng; Songjia Lai; Guangyou Yang
Journal:  Exp Appl Acarol       Date:  2014-04-13       Impact factor: 2.132

10.  Candidate vaccine antigens identified by antibodies from mice vaccinated with 15- or 50-kilorad-irradiated cercariae of Schistosoma mansoni.

Authors:  D Richter; D A Harn
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.